preloder
LONGEVITY 에 투자하십시오
LONGEVITY 에 투자하십시오

롱런에 투자하십시오

장수를위한 생활 조건의 전 범위
우리는 어떻게 당신의 삶을 향상 시킬지 안다
분산 된 생태계의 일부가 되십시오
글로벌 장수

Private ICO round successfully completed.

1 LONGEVITY = 0,00001 ETH
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.
법률 문서
백지
ONE PAGER & MVP
토큰의 법적 특성
KYC 순서
프로젝트 소개
세계적인 수명은 품질 수명의 전제 조건을 창조하는 분산되고 확장 가능한 생태계입니다. 블록 체인, 신경 네트워크 및 기계 학습을 기반으로 한 개인 맞춤형 수명 관리를 위해 IT 플랫폼의 모든 최신 업적을 사용하며 세계 과학 분야에서 활동합니다.
Longevity 소프트웨어 토큰은 Global Longevity에서 생성되며 해당 소유자에게 회사의 현재 및 향후 서비스에 대한 액세스 권한을 제공합니다. Global Longevity는 장수 시장에서 최고의 기술과 수년 간의 경험을 구현합니다.

LONGEVITY은 UTILITY TOKEN입니다.

비재무적인 도구이므로, 소유자에게 Global Longevity Market 및 Global Longevity Market에서 구입할 수있는 제품에 대한 액세스를 제공합니다.

우리의 미션

Global Longevity의 사명은 사람들에게 장수 기술의 고급 과학을 사용하여 삶을 확장 할 수있는 진정한 기회를 제공하는 것입니다.

분산 된 생태계의 일부가 되십시오

글로벌 장수

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

인생에서의 손님이되지 마십시오.

그녀가 HOST가되었습니다!

당신의 여정을 글로벌 장수로 시작하십시오

나는 영원히 살기로 결심했다. 그리고 이제까지는 모든 것이 잘됩니다.

알 수없는 작성자

LONGEVITY을 위해 구매할 수있는

바다와 아파트 주변의 토지 (구매 및 임대)

매력적인 리조트 및 레크리에이션 지역에서 부동산을 구매하고자하는 경우에도 광범위한 전망과 기회가 열리게됩니다. 외국 시민들에게 특히 인기가있는 지역은 조지아 – 아자 리아 지역이며, 특히 항구 도시인 바투 미어 (Batumi)시에서는 독특한 풍미를 선사합니다.

더 알아보기

진단 및 치료

신체의 완전한 진단은 특별한 장치의 도움과 다양한 검사의 전달을 통해 수행되는 포괄적 인 검사를 의미합니다. 얻은 데이터는 우리가 인간의 건강 상태, 내부 기관 및 새로운 형성 (양성 및 악성 모두)을 완벽하게 파악할 수있게 해줍니다.

더 알아보기

법적 도움

제공되는 서비스의 효율성은 우리를 안내하는 원칙에 기인합니다. 이것은 전문 변호사 훈련, 각 고객에 대한 개인적인 접근, 서비스 품질에 대한 책임, 교장의 희망과 관심에 중점을 둡니다.

더 알아보기

약리학 제품

이 산업은 주로 질병의 예방, 구제 및 치료를 목적으로 한 연구, 개발, 대량 생산, 시장 조사 및 의약품 유통과 관련이 있습니다. 현재 제약 산업은 가장 성공적인 산업 중 하나입니다.

더 알아보기

세계적인 장기를위한 유기농 식품

전 세계에서 유기농 식품의 생산이 호황을 누리고 있습니다. 이 식품은 현대 기술로 생산되는 제품에 비해 비타민, 미네랄 및 기타 영양소가 평균 10 ~ 50 % 더 많이 함유되어 있습니다. 유기농 식품은 건강을 증진시키고 면역력을 높이며 특히 어린이, 임산부 및 수유부모에게 유용합니다.

더 알아보기

관광 서비스

신선한 바람을 불어 넣고 새가 부르는 소리와 개울 소리가 들리면 환상적인 모험 세계로 뛰어 들기를 원합니다 – 바로 그 곳으로 왔습니다!

더 알아보기

채광

이 분야에서의 Global Longevity의 경험은 우리가 선도적 인 장비 제조업체 및 기술 업체와의 파트너십을 구축하는 데 도움을 주었으며,이를 통해 우리는 고객이 향후 채광 작업을 성공적으로 수행하고 수익을 창출 할 수 있도록 지원할 것입니다.

더 알아보기

ICO 및 STO 프로모션

전문 기술이 적절하게 결합되었을 때만 모든 목표를 성공적으로 달성 할 수 있습니다. 우리 팀의 모든 구성원은 숙련 된 전문가로서 범위에 중점을 둡니다.

더 알아보기
토큰
절대적으로 발행 된 토큰의 전체 볼륨은 1 개의 Longevity (0,00001 ETH) 비용이 0,001 ETH과 같다고하더라도 글로벌 장수 시장에서 제공되는 재화와 서비스를 완벽하게 제공합니다. 따라서 오늘날 토큰의 초기 성장 잠재력 9900 %입니다.
Name: LONGEVITY
Ticker: LGV
Type: ERC-20
Platform: Ethereum
Token Type: Utility
Token Price: 0,00001 ETH
Soft Cap: none
Hard Cap: 1.000.000 LGV
Return on Invest: long-term token value increase
Purchase methods accepted: All Leading Crypto and Fiat
Total token supply: 100.000.000.000 LGV
Private-sale & Public Sale: 89.000.000.000 LGV
Team: 5.000.000.000 LGV
Advisors: 3.000.000.000 LGV
Marketing Activities and Bounty: 3.000.000.000 LGV

토큰 유통의 백분율

자금 배분 및 사용

NOTES

  • Team’s token will be locked for 30 months after the Private-sale & Public Sale
  • Tokens for Marketing team and Bounty will be locked for 6 months after the Private-sale & Public Sale
Investor Exclusions: Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia.
ICO 단계
단계 Pre ICO
BONUS - 20%*

20.05.2019 - 31.05.2019

During this period, institutional investors will be given a bonus of 20%.

단계 ICO
BONUS - 10%*

01.06.2019 - 31.08.2019

During this period, institutional investors will be given a bonus of 10%.

로드맵
Jan 2014
Official opening Global Longevity Institute
Mar 2014
Approval of the concept of creating an ecosystem within the program of Global Longevity
Nov 2014
Selection and approval of the region for the pilot project of Global Longevity
Jan 2015
Initiation of a material base for a pilot project of Global Longevity
May 2017
Completion of work on the creation of a material basis for the pilot project of Global Longevity
Jul 2017
Deciding on the implementation of blockchain and cryptocurrency in the project of Global Longevity
Jan 2018
Start preparation for ICO Global Longevity
Dec 2018
Cryptocurrency issue Longevity
May 2019
Start Pre ICO
Jun 2019
Start ICO
Jul 2021
Full launch of the Global Longevity project
팀 및 고문

Elina Mahzhalii

CEO (Chief Executive Officer),
CEO Global Longevity Institute

MORE INFO

Wolfgang Stremmel

Professor of Internal Medicine IV

MORE INFO

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

Akaki Lomadze

Doctor of Medicine, Male Health Expert

Denys Matsepliuk

CIO (Chief Information Officer)

IT manager, information technology director, responsible for the acquisition and implementation of new technologies, information resources management.

Jīnlóng Xiàng

CLO (Chief Legal Officer)

Manager of legal informatization, director of legislative technologies. Advisor to the corporation, executive of the highest rank, responsible for the legal support of contracts, expert in cryptocurrency legislation.

Champ Janadar

CMO (Chief Marketing Officer)

Consultant in marketing and marketing strategy of the enterprise, manages the work of the marketing service of the enterprise.

Guāngmíng Bō

One of the leaders of the travel direction of the corporation, responsible for its development and development of new tourism products.

IURII NAZAROV

Owner, Founder, Board Chair, Professor of Medicine

LIU JUAN

Professor of Medicine

DEEPAKA ABEESEKARA

Doctor of Medicine

JOAQUIM SILVA

Doctor of Medicine

ALBERTO RODRIGUEZ

Doctor of Medicine

METIN OZTURK

Doctor of Medicine

PETER WOLLY

Doctor of Medicine

DIEGO MARTINEZ

Doctor of Medicine

RAJ AHIRWAR

Doctor of Medicine

LUONG NGUYEN

Doctor of Medicine

MARIA VICTORIA ROJAS

Doctor of Medicine

ADISA NGCOBA

Doctor of Medicine

TERESA GUEVARA

Doctor of Medicine

TAN YEE POH

Doctor of Medicine

NADIA JIMENEZ

Doctor of Medicine

앞으로 나아갈 단계 만들기장수!

당신의 여정을 글로벌 장수로 시작하십시오
파트너
뉴스 및 출판물
(출판물을 위해 계획된 간행물)
미국과 접촉하자

 

Global Longevity Disclaimer

Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.

I agree What is Disclaimer?